GLUE
Monte Rosa Therapeutics, Inc.NASDAQHealthcare$17.09-0.47%ClosedMarket Cap: $1.11B
As of 2026-04-06
Insider Statistics (Q1 2026)
Purchases
12
Sales
16
Buy/Sell Ratio
0.75
Total Bought
$0.00
Total Sold
$14.00
Recent Insider Trades
| Filing Date | Name | Type | Action | Shares | Price | Shares After |
|---|---|---|---|---|---|---|
| Thu Mar 05 | Dunn Edmund | officer: Principal Accounting Officer | Sell | 139 | $17.96 | 22,554 |
| Wed Mar 04 | Warmuth Markus | director, officer: President & CEO | Sell | 5,466 | $17.92 | 613,471 |
| Mon Mar 02 | Dunn Edmund | officer: Principal Accounting Officer | Sell | 25,164 | $13.41 | 47,857 |
| Mon Mar 02 | Dunn Edmund | officer: Principal Accounting Officer | Sell | 536 | $13.41 | 23,229 |
| Mon Mar 02 | Dunn Edmund | officer: Principal Accounting Officer | Sell | 536 | $17.50 | 22,693 |
| Mon Mar 02 | Dunn Edmund | officer: Principal Accounting Officer | Sell | 25,164 | $18.10 | 22,693 |
| Tue Feb 24 | Janku Filip | officer: Chief Medical Officer | Sell | 9,189 | $19.50 | 65,837 |
| Fri Jan 09 | Warmuth Markus | director, officer: President & CEO | Sell | 3,707 | $23.24 | 620,696 |